New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 24, 2014
11:07 EDTJBL, RAD, SWHC, MU, RHT, MTOR, APD, ADBE, PIR, VRTXOptions with decreasing implied volatility
Options with decreasing implied volatility: VRTX MTOR SWHC PIR RHT RAD ADBE MU JBL APD
News For VRTX;MTOR;SWHC;PIR;RHT;RAD;ADBE;MU;JBL;APD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
March 17, 2015
16:08 EDTADBEAdobe down 3.3% after Q1 earnings report
Subscribe for More Information
16:07 EDTADBEAdobe says 70% of Q1 revenue from recurring sources
70% of Adobe’s Q1 revenue was from recurring sources, compared to 52% of Q1 revenue in fiscal 2014. Creative Annualized Recurring Revenue grew to $1.79B, and total Digital Media ARR grew to $2.09B. Adobe Marketing Cloud revenue was $311M.
16:06 EDTADBEAdobe reports Q1 adjusted EPS 44c, consensus 39c
Reports Q1 revenue $1.11B, consensus $1.09B. Adobe added 517K net new Creative Cloud subscriptions in the quarter, which represents 28% year-over-year growth when compared to net new subscription additions in Q1 fiscal year 2014.
15:18 EDTADBENotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Oracle (ORCL), consensus 68c... Adobe (ADBE), consensus 39c.
14:21 EDTADBEAdobe technical comments ahead of results
The shares are trading close to the lifetime high at $80.30 ahead of earnings. On strong bullish news, a breakout above that life high would be highly probable, opening up a run to the $85 to $90 area. If the news is bearish, contrary to current expectations, the first significant test of support isn't until the 50-day moving average at $74.55. A breakdown below the 50-day would be bearish, breaking the longer-term uptrend. Next support below would be at $72.24 and then at the $70 area. The $70 level has previously been an important area of resistance and more recently support.
13:53 EDTADBEAdobe March 80 straddle priced for 5.2% movement into Q1
Subscribe for More Information
11:16 EDTMUMicron falls, levels to watch
Subscribe for More Information
08:00 EDTMUMicron FY16 EPS estimate lowered at RBC Capital
Subscribe for More Information
07:01 EDTADBEAdobe March volatility increases into Q1 and outlook
Subscribe for More Information
March 16, 2015
10:02 EDTJBLOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AmerisourceBergen (ABC) upgraded to Buy from Neutral at UBS... Avago (AVGO) upgraded to Buy from Neutral at DA Davidson... Francesca's (FRAN) upgraded to Buy at Janney Capital... Goldcorp (GG) upgraded to Overweight from Neutral at HSBC... Jabil Circuit (JBL) upgraded to Buy from Hold at Cross Research... JetBlue (JBLU) upgraded to Outperform at Raymond James... King Digital (KING) upgraded to Overweight from Neutral at JPMorgan... L.B. Foster (FSTR) upgraded to Outperform from Neutral at Macquarie... NextEra Energy (NEE) upgraded to Buy from Hold at Deutsche Bank... Petrobras Argentina (PZE) upgraded to Buy from Neutral at BofA/Merrill... Qorvo (QRVO) upgraded to Buy from Neutral at DA Davidson... Randgold (GOLD) upgraded to Overweight from Neutral at HSBC... Royal Gold (RGLD) upgraded to Overweight from Neutral at HSBC... Seagate (STX) upgraded at Needham... Standex (SXI) upgraded to Buy from Hold at BB&T... Union Pacific (UNP) upgraded to Outperform from Neutral at Macquarie... West Corp. (WSTC) upgraded to Outperform from Neutral at RW Baird... Xilinx (XLNX) upgraded to Buy from Hold at Drexel Hamilton... YPF (YPF) upgraded to Buy from Neutral at BofA/Merrill.
08:24 EDTMUMicron pricing pressure to ease in 2H15, says Deutsche Bank
Deutsche Bank lowered its estimates on Micron to reflect near-term PC DRAM weakness, but the firm expects pricing pressure to ease in 2H15, driven by seasonal PC build, higher mobile content and a DDR4 upgrade cycle. The firm thinks the company will have a number of positive catalysts in 2016, and it keeps a $40 price target and Buy rating on the shares.
06:04 EDTJBLJabil Circuit upgraded to Buy from Hold at Cross Research
Subscribe for More Information
March 13, 2015
11:19 EDTVRTXBioMarin rallies amid positive call on DMD drug timeline, takeover rumor
The shares of drug maker BioMarin (BMRN) are climbing after research firm Jefferies quoted a regulatory expert as saying that the company's drisapersen drug has a good chance of being approved on an accelerated basis by the FDA. Drisapersen is a treatment for Duchenne Muscular Dystrophy, or DMD. WHAT'S NEW: "There is a strong possibility" that the FDA will grant accelerated approval to drisapersen because there is currently no approved drug for the treatment of DMD, Jefferies analyst Eun Yang quoted the expert as saying. The expert is also optimistic about the outlook for accelerated approval because she had a good experience working with BioMarin while she was with the FDA and because BioMarin has a favorable track record with the FDA, according to Yang. There is a 60% chance that drisapersen will be approved by the end of this year and the stock can rise to $155, versus its current level of about $121.50, if that does occur, the analyst stated. Yang's price target on the stock increased to $135 from $125 and the analyst kept a Buy rating on the shares. WHAT'S NOTABLE: Pharmaceutical giant AstraZeneca (AZN) has been rumored to be interested in buying BioMarin for $175 per share in cash, British newspaper Daily Mail reported. , Piper Jaffray analyst Joshua Schimmer wrote in a note to investors this morning that BioMarin, along with Vertex (VRTX) and Incyte (INCY), have a "clear path" to joining the group of companies with market caps of over $10B projected to deliver greater than 20% EPS CAGR, which the analyst identified as a set of criteria that has previously pointed to companies that make good potential takeover targets. PRICE ACTION: In mid-morning trading, BioMarin climbed nearly 4% to $120.
09:33 EDTADBEAdobe upgraded to Positive from Mixed at OTR Global
Subscribe for More Information
08:51 EDTJBLJabil Circuit March volatility elevated into Q2 and outlook
Subscribe for More Information
March 12, 2015
14:21 EDTADBEAdobe March volatility elevated at 47 into Q1 and outlook
Subscribe for More Information
13:22 EDTRHTRed Hat April volatility elevated into Q4 and outlook
Red Hat March call option implied volatility is at 25, April is at 35, June is at 29, September is at 26; compared to its 26-week average of 31 according to Track Data, suggesting large April price movement into the expected release of Q4 results on March 25.
13:06 EDTMUHP rises fractionally despite Barclays downgrade, Intel guidance cut
Subscribe for More Information
11:04 EDTMUIntel cut on PC weakness a slight negative for Micron, Marvell, says Ladenburg
Subscribe for More Information
09:54 EDTMUPiper calls Intel warning 'disappointing,' keeps Overweight rating
Piper Jaffray calls Intel's (INTC) reduced Q1 outlook "disappointing" but says it continues to expect a modest consumer refresh cycle later this year to partially offset the declines in the corporate segment. It keeps an Overweight rating on Intel. Piper notes it still views Micron (MU) positively despite the weakness in PCs highlighted by Intel. It finds the stock attractively valued.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use